Context Therapeutics Inc Strategic Asset Allocation Index
Context Therapeutics Inc strategic asset allocation index. Context Therapeutics Inc (CNTX) has a Strategic Asset Allocation Index of 0.1% as of June 2023. Strategic assets (PP&E of $28.70K plus long-term investments of $-) total $28.70K, measured against net assets of $24.00 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Context Therapeutics Inc (CNTX) balance sheet quality index to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Context Therapeutics Inc (2016–2017)
Strategic asset allocation index of Context Therapeutics Inc from 2016 to 2017. This chart shows how Context Therapeutics Inc's Strategic Asset Allocation Index has evolved across 2 annual periods from 2016 to 2017. As of June 2023, the index stands at 0.1%, representing strategic assets of $28.70K against net assets of $24.00 Million USD. Check Context Therapeutics Inc tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Context Therapeutics Inc Strategic Asset Allocation Index by Year (2016–2017)
Context Therapeutics Inc strategic asset allocation index by year from 2016 to 2017. The table below presents the year-by-year Strategic Asset Allocation Index for Context Therapeutics Inc from 2016 to 2017, covering 2 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Context Therapeutics Inc (CNTX) total market value.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2017 | 0.0% | $29.00K | $29.00K | $- | $58.95 Million | ▼ -0.4 pp |
| 2016 | 0.5% | $60.00K | $60.00K | $- | $13.12 Million | — |